Фото: Ajeng Dinar Ulfiana / Reuters
The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
，更多细节参见新收录的资料
Frontier Airlines
Трамп объяснил выбор названия операции в Иране01:56
�@�V���ɔ��\���ꂽiPhone 17e�́A����iPhone�̂悤�ȉ��ʂ̏펞�_���ɂ͑Ή������A���炭���u�����Ɛߓd�̂��߉��ʂ��I�t�ɂȂ��B �����ł��A�قƂ��ǂ̐l�ɂ͂����ŏ\���ŁA�����ǂ��납����1�����Y�d�l�̂������ɂ����A�w�ʂ̌����ڂ̓X�b�L���Ƃ��Ĕ������B